2 Polen Capital Lilly(Eli) & Trades
Polen Capital's position in Lilly(Eli) & is currently worth $436 Million. That's 1.00% of their equity portfolio (22nd largest holding). Polen Capital started to build up the position in Lilly(Eli) & in Q3 2023. Since then they sold 29 Thousand shares. The stake costed the investor $306 Million, netting the investor a gain of 42% so far.
News about Lilly(Eli) & Co and Polen Capital
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis supp...
Archford Capital Strategies LLC Increases Stock Position in Eli Lilly and Company (NYSE:LLY)
… stock. Eli Lilly and Company Stock Performance Shares of Eli Lilly and Company … insiders. Eli Lilly and Company Company Profile (Free Report) Eli Lilly an...
Eli Lilly and Company (NYSE:LLY) Stock Holdings Decreased by Capital International Investors
… company’s stock. Eli Lilly and Company Stock Performance Eli Lilly and Company stock … s stock. Eli Lilly and Company Profile (Free Report) Eli Lilly and C...
The Next Trillion-Dollar Companies: 3 Stocks to Buy Now
The hunt for the next trillion-dollar companies invariably ignites investor excitement. Moreover, the AI-led excitement in equities this year pushed tech sto...